Literature DB >> 12383813

Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization.

Grazia Pertile1, Carl Claes.   

Abstract

PURPOSE: The aim of this study is to evaluate the functional outcome in a group of patients treated with full macular translocation (FMT) with 360-degree retinotomy for treatment of age-related macular degeneration (ARMD) with subfoveal choroidal neovascularization.
DESIGN: Consecutive interventional case series.
METHODS: Fifty consecutive eyes (50 patients) with ARMD and subfoveal neovascularization who underwent a FMT in our department from January 1999 to July 2000 are included in this study. Compensatory muscle surgery, as described by Eckardt and associates, was performed on all the eyes. The median follow-up is 21 months (range, 12 to 36; SD, 5.4).
RESULTS: The best-corrected postoperative visual acuity (BCVA) was improved by 2 or more Snellen lines in 33 eyes (66%) and remained stable (+/-1 line) in 14 eyes (28%). Only 3 eyes (6%) experienced a deterioration of the BCVA of 2 or more lines. The final BCVA was 20/50 or better in 32% of the cases; only 8 eyes (16%) had a final BCVA < 20/200. Thirty-four (68%) patients are able to read newspaper print (3.3/10) with normal (+3 diopters to +4 diopters) or increased (+5 diopters to +8 diopters) reading ads. Other patients are able to read with magnifying systems. Complications included proliferative vitreoretinopathy (PVR) in 9 eyes (18%), recurrent choroidal neovascularization in 5 eyes (10%), diplopia in 3 eyes (6%), choroidal hemorrhage in 2 eyes (4%), macular hole in 1 eye, and temporary hypotony in 1 eye.
CONCLUSIONS: As 68% of the patients in the study group regained reading vision with reading glasses, FMT can be considered an effective approach in cases of subfoveal choroidal neovascularization. Further investigations are necessary to determine which patients will have the most benefit from this complex therapeutic method.

Entities:  

Mesh:

Year:  2002        PMID: 12383813     DOI: 10.1016/s0002-9394(02)01641-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  21 in total

1.  Age related macular degeneration: macular relocation surgery was not taken into account.

Authors:  David Wong; David G Charteris; Lyndon da Cruz
Journal:  BMJ       Date:  2003-06-28

2.  Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy.

Authors:  Cynthia A Toth; Deborah J Lapolice; Avie D Banks; Sandra S Stinnett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-05       Impact factor: 3.117

3.  Visual function 5 years or more after macular translocation surgery for myopic choroidal neovascularisation and age-related macular degeneration.

Authors:  K Takeuchi; S Kachi; E Iwata; K Ishikawa; H Terasaki
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

4.  A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent.

Authors:  D Wong; J C Van Meurs; T Stappler; C Groenewald; I A Pearce; J N McGalliard; E Manousakis; E N Herbert
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

5.  [Subretinal surgery for massive hemorrhage].

Authors:  P Szurman
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

6.  Compound subretinal prostheses with extra-ocular parts designed for human trials: successful long-term implantation in pigs.

Authors:  Florian Gekeler; Peter Szurman; Salvatore Grisanti; Ulrike Weiler; Rolf Claus; Tim-Oliver Greiner; Michael Völker; Konrad Kohler; Eberhart Zrenner; Karl Ulrich Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

7.  Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.

Authors:  Lyndon da Cruz; Kate Fynes; Odysseas Georgiadis; Julie Kerby; Yvonne H Luo; Ahmad Ahmado; Amanda Vernon; Julie T Daniels; Britta Nommiste; Shazeen M Hasan; Sakina B Gooljar; Amanda-Jayne F Carr; Anthony Vugler; Conor M Ramsden; Magda Bictash; Mike Fenster; Juliette Steer; Tricia Harbinson; Anna Wilbrey; Adnan Tufail; Gang Feng; Mark Whitlock; Anthony G Robson; Graham E Holder; Mandeep S Sagoo; Peter T Loudon; Paul Whiting; Peter J Coffey
Journal:  Nat Biotechnol       Date:  2018-03-19       Impact factor: 54.908

8.  Can macular translocation be a satisfactory management of subfoveal choroidal neovascular membrane?

Authors:  Arpád Bereczki; Zsolt Bíró
Journal:  Clin Ophthalmol       Date:  2008-06

9.  Age-related macular degeneration: current treatments.

Authors:  Jean Pierre Hubschman; Shantan Reddy; Steven D Schwartz
Journal:  Clin Ophthalmol       Date:  2009-06-02

10.  [Transplantation of retinal pigment pithelium (RPE) following CNV removal in patients with AMD. Techniques, results, outlook].

Authors:  A Bindewald; F Roth; J Van Meurs; F G Holz
Journal:  Ophthalmologe       Date:  2004-09       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.